Rethinking the Win Ratio: A Causal Framework for Hierarchical Outcome Analysis
重新审视胜率比：层级结局分析的因果框架AI 解读 ↓
← 返回论文列表与筛选
阅读说明
本页整理公开书目信息，不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成，未完成全文核验，可能有误；具体假设、证明与结论请核对原文。摘要保留来源文本，未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要；缺少可靠材料时保留待补状态。
本页为预印本版本；arXiv 收录、作者填写的期刊信息以及作者既有发表经历，都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对，只展示已核实例，档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录，不合计多个记录；关联记录可能包含正式发表版本，不等于此版本单独引用。缺失不视为零，引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配，同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列，再参考通用方法与发表日期。
分类依据与纠错
AI 根据所提供的论文材料归类：摘要直接讨论因果目标量的可识别性，并用分布回归处理层级多元结局的治疗比较。
反馈分类问题
正在核对关联版本…
代码、数据与补充材料
正在核对对应版本的资源…
关注这篇论文的作者
重新审视胜率比：层级结局分析的因果框架
- 研究问题
- 面对按优先级比较的多元结局，如何区分跨个体的总体比较与同一个体的治疗获益，并构造更接近后者且可识别的因果指标？
- 方法与思路
- 作者提出新的个体层面因果度量，用处理组和对照组的最近邻配对估计，并进一步构建分布回归及半参数有效估计方法。
- 材料陈述的贡献
- 摘要称新指标可识别，最近邻配对的胜率比或净获益可估计该指标，并以模拟及 CRASH-3 试验应用展示方法。
- 阅读关注点
- 应核对新指标与理想个体获益概率的差别、随机与观察研究各自的识别条件，以及最近邻配对与有效估计量之间的关系。
- 阅读边界
- 依据 arXiv 预印本摘要，同行评审及期刊接收未经核实；新指标接近理想指标并不意味着识别了后者，摘要未展开相关条件。
原文摘要
Quantifying causal effects in the presence of complex and multivariate outcomes remains a key challenge in treatment evaluation. For hierarchical multivariate outcomes, the FDA recommends the Win Ratio and Generalized Pairwise Comparisons approaches \citep{Pocock2011winratio,Buyse2010}. However, commonly used estimators can yield treatment recommendations that target a population-level estimand (the probability that a randomly sampled patient under treatment fares better than another randomly sampled patient under control), which can contradict conclusions drawn from an ideal estimand (the probability that an individual would fare better with treatment than without), especially in heterogeneous populations. This discrepancy arises from the non-identifiability of the latter estimand and underscores both the influence of the chosen causal measure on the resulting conclusions and the necessity of articulating the underlying causal framework with clarity. We propose a novel, individual-level yet identifiable causal effect measure that more closely approximates the ideal individual-level estimand. We show that computing the Win Ratio or Net Benefit via nearest-neighbor pairing between treated and control patients, which can be seen as an extreme form of stratification, yields an estimator of our new causal measure in both randomized controlled trials and observational settings. We then develop a distributional regression framework, alongside semiparametric efficient estimators. Our methods are simple to implement and readily applicable in practice. We evaluate the proposed approach through simulations and apply it to the CRASH-3 trial \citep{crash3}, a major study assessing the effects of tranexamic acid in patients with traumatic brain injury.